Financials
Cash Data
- Monthly Burn
- Burn Trend
- Dilution Risk
- SEC Filing
Key Stats
Upcoming Catalysts
FDA decisions, readouts and PDUFA dates · scored by probability of approval
| Catalyst | Drug / Treatment | Stage | Prob. of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|
MTEX Catalyst Timeline
Dated clinical, regulatory and corporate events for Mannatech, Incorporated
Catalyst Timeline
Dated clinical, regulatory & corporate events for Mannatech, Incorporated
Event history 50
Past FDA Catalysts and PDUFA Decisions
How MTEX actually traded into and out of each decision
| Date | Drug | Catalyst | Stage | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|
| No matching catalysts | ||||||
Drug Pipeline Intelligence
Clinical Trial Results
Readouts, endpoints and source filings for every MTEX program
| Drug Name | Indication | Phase | Date | Trial Results Summary | Title | Source |
|---|
Inside Trades
| Insider | Side | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| JOBE LARRY ADirector | Buy | 2,803 70,000 held | $4.12 | 05/20/2026 |
Hedge Fund 13F Activity
Hedge Funds invested in MTEX
| Fund | % of Portfolio | Current MV | Shares Owned | Activity |
|---|---|---|---|---|
| No hedge fund reported a 13F position in MTEX for Q3 2026. | ||||
Ownership Trends
MTEX Short Interest
Shares sold short, counted twice a month.
Options Data
Option Volume
Option Chain Statistics
| Expiry | Call Vol | Put Vol | Vol P/C | Call OI | Put OI | OI P/C | IV Call | IV Call OI-Wtd | IV Call Vol-Wtd | IV Put | IV Put OI-Wtd | IV Put Vol-Wtd |
|---|
Real-Time Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last | Vol | OI | Last | Vol | OI | |
| No data available | ||||||
Calls vs Puts by Expiry
Competitive positioning
How MTEX ranks across every disease it competes in
MTEX News
Mannatech Reports Financial Results for Third Quarter 2026
Mannatech reported third quarter 2026 financial results, showing net sales of $24.9 million, down $4.3 million from the previous year. The company experienced a significant income tax benefit of $10.9 million, leading to a net income of $8.9 million. However, operational income dropped to $0.3 million, reflecting challenges in sales and recruitment.
Read more →Mannatech Reports Financial Results for Second Quarter 2026
Mannatech reported a net sales increase of $1.0 million for Q2 2026, totaling $26.7 million. The gross profit margin rose to 76.9%, and the company achieved an operating income of $1.0 million, reversing a loss from the previous year. However, cash reserves fell by 2.4%, and the number of independent associates declined.
Read more →Mannatech Reports Financial Results for First Quarter 2026
Mannatech announced its financial results for the first quarter of 2026, highlighting the impact of trade policy changes on its cost structure. The company also provided non-GAAP financial measures to offer investors additional insights into its performance. However, operational constraints may hinder efforts to manage increased costs.
Read more →Mannatech Reports Financial Results for Fourth Quarter and Year Ended 2025
Mannatech reported a challenging financial year for 2025, with net sales declining to $108.0 million, down 8.3% from 2024. The company faced significant losses, recording a net loss of $15.2 million, largely due to tax provisions and operational challenges. Despite reduced expenses, the impact of foreign exchange and a new ordering system hindered sales growth.
Read more →Mannatech Reports Financial Results for Third Quarter 2025
Mannatech reported its third quarter 2025 financial results, revealing net sales of $29.2 million, down 8.1% from the previous year. Despite a decline in sales, gross profit margin increased to 76.4%, and net income improved to $1.9 million. The company also noted a significant drop in cash reserves and a decrease in new associate recruitment.
Read more →Mannatech Reports Financial Results for Second Quarter 2025
Mannatech reported a net sales decline of 7.4% in Q2 2025, totaling $25.7 million. The gross profit margin decreased to 73.6%, attributed to rising freight costs and sales promotions. The company experienced a net loss of $4.3 million, significantly higher than the previous year's loss of $0.6 million.
Read more →Mannatech Announces Promotion of Peter Griscom to Chief Operating Officer
Mannatech has promoted Peter Griscom to Chief Operating Officer effective July 1, 2025. With over a decade of experience in direct selling and consumer goods, Griscom aims to enhance operational efficiencies. His previous roles include senior vice president of global operations and product innovation. The CEO believes this promotion will benefit the company's future.
Read more →Mannatech Announces Results of Annual Shareholders’ Meeting
Mannatech held its annual shareholder meeting on June 3, 2025, where all proposals were approved. Shareholders elected J. Stanley Fredrick and Tyler J. Rameson to the Board of Directors. The appointment of BDO USA, P.C. as the accounting firm for 2025 was ratified. Additionally, the compensation of executive officers was approved.
Read more →Mannatech Premieres Powerful New Documentary on Marathon Legend Steve Edwards
Mannatech premiered a documentary on Steve Edwards, who holds the world record for 1,000 marathons. The film highlights his use of the company's Glycan Replenishment Therapy to support recovery and longevity. Edwards credited the supplements for enabling his endurance into his 60s despite genetic challenges.
Read more →Mannatech Reports Financial Results for First Quarter 2025
Mannatech reported a net loss of $1.5 million for Q1 2025, a significant decline from a net income of $1.2 million in Q1 2024. Net sales fell to $26.6 million, down 9.6% year-over-year, primarily due to reduced demand in Asia. The company also experienced a decrease in commission expenses and selling costs, but overall profitability remains challenged.
Read more →Mannatech Reports Fourth Quarter 2024 Financial Results
Mannatech reported its fourth quarter 2024 financial results, showing net sales of $29.0 million, down 11.3% from the previous year. Despite the decline in sales, the company achieved a net income of $2.3 million, an improvement from a loss in Q4 2023. Cost management led to a reduction in selling and administrative expenses, contributing to a positive operating income.
Read more →Mannatech Declares First Quarter 2023 Dividend
Mannatech, Incorporated has announced a cash dividend of $0.20 per share for the first quarter of 2023, scheduled for payment on June 29, 2023. This declaration signifies the company's dedication to providing value to its shareholders and promotes long-term investment. The company, which has been in operation for over 25 years and is active in 25 markets, emphasized its commitment to enhancing lives through health and wellness products. However, the announcement included forward-looking statements that caution investors about various potential risks and uncertainties facing the company.
Read more →Mannatech Announces New Tiered Affiliate Program Pre-Launch
Mannatech, Incorporated (NASDAQ MTEX) has announced the anticipated launch of its new tiered affiliate program on June 16, 2023, through a wholly owned subsidiary named Trulu. This program aims to innovate in customer acquisition and retention while leading with improved product offerings such as the AMPM powders, designed to support various aspects of health. Mannatech, which has been operational for over 25 years and serves 25 markets, is committed to providing high-quality health products and adapting to the gig economy. The announcement emphasizes the potential for enhanced market share and profitability.
Read more →Mannatech Announces Formation of Subsidiary to Serve as Innovation Hub
Mannatech, Incorporated (NASDAQ: MTEX) has announced the establishment of a wholly owned subsidiary intended to serve as an innovation hub, named Trulu. This new entity is designed to capitalize on the growing gig economy by providing a simplified business opportunity focused on health and wellness. While operating separately from Mannatech, Trulu will still collaborate closely with the parent company, emphasizing the ongoing commitment to Mannatech's existing business model while exploring new growth avenues. The initiative highlights Mannatech's recognition of the necessity to adapt its business strategies to remain competitive in the marketplace.
Read more →Mannatech Declares Fourth Quarter 2022 Dividend
Mannatech, Incorporated has announced that its Board of Directors declared a cash dividend of $0.20 per share of common stock. This dividend is set to be paid on March 30, 2023, to shareholders on record as of March 16, 2023. The company emphasizes its commitment to rewarding shareholders and promoting long-term investment. Mannatech has been operational for over 25 years, focusing on health and wellness products through a global network.
Read more →Mannatech Declares Third Quarter 2022 Dividend
MEDIA CONTACT Donna Giordano 972-471-6512 ir mannatech.com Mannatech Declares Third Quarter 2022 Dividend (Flower Mound, Texas) November 11, 2022 - Mannatech, Incorporated (NASDAQ MTEX), a global health and wellness company committed to transforming lives to make a better wor
Read more →Mannatech Announces Share Repurchase Program
MEDIA CONTACT Donna Giordano 972-471-6512 ir mannatech.com Mannatech Announces Share Repurchase Program FLOWER MOUND, Texas (BUSINESS WIRE) September 20, 2022 - Mannatech, Incorporated (NASDAQ MTEX), ("Mannatech"), today announced that its Board of Directors has approved a sh
Read more →Mannatech Declares Second Quarter 2022 Dividend
MEDIA CONTACT Donna Giordano 972-471-6512 ir mannatech.com Mannatech Declares Second Quarter 2022 Dividend (Flower Mound, Texas) August 30, 2022 - Mannatech, Incorporated (NASDAQ MTEX), a global health and wellness company committed to transforming lives to make a better worl
Read more →Mannatech Declares First Quarter 2022 Dividend
MEDIA CONTACT Donna Giordano 972-471-6512 ir mannatech.com Mannatech Declares First Quarter 2022 Dividend (Flower Mound, Texas) June 3, 2022 - Mannatech, Incorporated (NASDAQ MTEX), a global health and wellness company committed to transforming lives to make a better world, a
Read more →Mannatech Declares Fourth Quarter 2021 Dividend
MEDIA CONTACT Donna Giordano 972-471-6512 ir mannatech.com Mannatech Declares Fourth Quarter 2021 Dividend (Flower Mound, Texas) March 4, 2022 - Mannatech, Incorporated (NASDAQ MTEX), a global health and wellness company committed to transforming lives to make a better world,
Read more →